Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Human clinical trial data is limited, which is common across the peptide landscape
[7] In a 2026 neuropathic-pain study, photoaffinity-probe experiments identified LanCL1 as a binding target of LAT8881-derived probe material in nervous-system models, and LanCL1 knockdown blocked the reported LAT8881 activity in those models
Data availability This manuscript does not have data that need to be deposited in a public database
This personalized approach allows patients to receive targeted support for their wellness journey
US$ 21.54
US$ 26.13
US$ 20.06
US$ 21.42
US$ 20.59
